Silver Book

Silver Book Fact

Over 6 years, flu vaccine prevented ~13 million cases

Over a 6-year period (2005 – 2011), the influenza vaccine prevented an estimated 13 million influenza cases–between 1.1 million and 5 million annually.

Kostova, Deliana, Carrie Reed, Lyn Finelli, Po-Yung Cheng, Paul M. Gargiullo, et al. Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005-2011. PLoS ONE. 2013; 8(6): e66312. doi:10.1371/journal.pone.0066312. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0066312

Reference

Title
Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005-2011
Publication
PLoS ONE
Publication Date
2013
Authors
Kostova, Deliana, Carrie Reed, Lyn Finelli, Po-Yung Cheng, Paul M. Gargiullo, et al.
Volume & Issue
Volume 8, Issue 6
Pages
e66312. doi:10.1371/journal.pone.0066312.
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Use of shingles vaccines significantly reduced disease burden
    Use of a live attenuated VZV (varicella-zoster vaccine) in a randomized trial reduced the burden of illness from shingles by 61.1% and the incidence of postherpetic neuralgia (PHN) by 66.5%.  
  • Vaccines cost ~$50 per healthy life year saved
    Most vaccinations cost less than $50 per healthy life year saved. In contrast, treating hypertension costs between $4,340 and $87,940 per healthy life year saved.  
  • Pre-surgery antibiotic use reduces 6-day mortality by 50% in elderly
    Effective pre-surgery antibiotic use can reduce 60-day mortality in the elderly by 50%.  
  • Shingles vaccine could improve QALY and save money
    Vaccination of 1 million people age 60 and over with the shingles vaccine would result in 11,919 non-discounted and 8,782 discounted QALYs (quality of life years) gained and save around…  
  • Effectiveness of pneumonia vaccine
    PPSV23 (pneumococcal polysaccharide vaccine) protects against 23 types of pneumococcal bacteria and is 60% to 80% effective in preventing pneumococcal bacteremia in adults over the age of 65 who are…